study the roles of antigen receptors in the immunology of cancer cells. Through extensive cell-based biological and immunological studies, both anti-antigen receptors and RP215 were found to demonstrate
screening, it could be a reproducible and cost-effective way of testing compared to cell-based or animal tests. Dosage forms produced by various formulation strategies could be investigated with
long after viral clearance in plasma. Furthermore, infectious CHIKV was detected in urine by cell-based immunofluorescence and 50% tissue culture infective dose (TCID50) assays, suggesting the presence of infectious
regenerative medicine applications is the availability of clinically acceptable off-the-shelf tissue and cell-based products. Cryopreserved adipose tissue (AT) represents a valid approach to this aim. Our previous
explored the mechanism of action of BNFA-D in breast cancer cells using multiple cell-based assays such as MTT, DAPI, FACS, Western blot and immunoprecipitation. BNFA-D caused apoptosis
that alter early inflammation, tissue homeostasis and tissue damage (1-3). We use relevant cell-based in vitro assays and in vivo models to assign specific IL-6 mediated molecular
tumour at various timepoints will enable an effective clinical trial strategy for mesenchymal stem cell-based cancer therapies to be developed and replicated with different cancers and treatment sites
vaccine strategies have already used such as live-attenuated microbes, viral vectors and dendritic cell-based vaccines led to suppress and/or clear infections. Among them, improved DNA vaccines have
appear to be valuable in restoring the lost vision. Now-a-days, cell-based therapy has gained a momentum in the treatment of AMD. Case Report: We report a case
engineering of urothelial tissue requires biomaterials as cell carriers that increase the stability of cell-based implants. The aim of this study was to investigate a new highly standardized, industrially
Mesenchymal stem cells (MSCs) show enormous potential for cell-based therapy in the treatment of various diseases. In the present report, the genetic manipulation of canine MSCs isolated from adipose
sources of stem cells. However, comparative studies to decide the most suitable cells for cell-based therapeutics are largely lacking. This study attempted to compare the potential of PDSCs
Rationale: Equine mesenchymal stem cells (eMSCs) and platelet-rich plasma (PRP) are cell-based therapies being used clinically to repair damaged tissue of horses. Numerous reports including data from
secrete high levels of biologically active ECSOD. Our findings suggest that mesenchymal stem cell-based antioxidant gene therapy has the potential for mitigation of radiation injuries in humans
with cells involving uptake, release and targeting selectivity. The size effects of nanocomplex on cell-based targeted delivery were studied to investigate if this phenomenon can be employed to combine
regenerative medicine has benefited from the exponential development of nanomaterial sciences, tissue engineering and cell-based therapies. More and more sophisticated designed structures and surface topologies are…
contrast to the reprogramming adult somatic cell is expected to develop isogenic ES cell-based therapies for the prevention and treatment of MS associated with mtDNA mutations that may open
micromolar range. The ability of the PPAR activation was evaluated in a cell-based reporter-gene assay. At a micromolar concentration, relative activations could be demonstrated, ranging from full agonists
history but is principally focused on the area of zoonotic diseases. The emergence of cell-based therapy has opened the door for a much broader application of the concept
These results demonstrate that placenta-derived MSCs may have important clinical applications in stem cell-based glioma therapeutics. Moreover, these studies provide a novel approach for the targeted delivery
presence of the hormone or EDCs acting on this particular receptor. Using this cell-based assay we detected androgen activity in 35% of the tested water samples, and a previously
cure? of HIV whereby virus suppression is maintained in the absence of antiretroviral therapy. Cell-based therapiesare gaining momentum as a testable approach in this front. Following the clinical success
should be based on scientific rationale and toxicology level of concern. The in vitro cell-based cytotoxicity assays are potential approaches to be applied especially in preliminary toxicological studies
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.